story of the week
Effect of Combination Treatment With GLP-1 Receptor Agonists and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
BMJ 2024 Apr 25;[EPub Ahead of Print], N Simms-Williams, N Treves, H Yin, S Lu, O Yu, R Pradhan, C Renoux, S Suissa, L AzoulayFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.